Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells
kawano, Y.; Kawano, H.; Ghoneim, D.; Fountaine, T. J.; Byun, D. K.; LaMere, M. W.; Mendler, J. H.; Ho, T.-C.; Salama, N. A.; Myers, J. R.; Hussein, S. E.; Frisch, B. J.; Ashton, J. M.; Azadniv, M.; Liesveld, J. L.; Kfoury, Y.; Scadden, D. T.; Becker, M. W.; Calvi, L. M.
Show abstract
Mesenchymal stem/stromal cells (MSCs) within the bone marrow microenvironment (BMME) support normal hematopoietic stem and progenitor cells (HSPCs). However, the heterogeneity of human MSCs has limited the understanding of their contribution to clonal dynamics and evolution to myelodysplastic syndromes (MDS). We combined three MSC cell surface markers, CD271, VCAM-1 (Vascular Cell Adhesion Molecule-1) and CD146, to isolate distinct subsets of human MSCs from bone marrow aspirates of healthy controls (Control BM). Based on transcriptional and functional analysis, CD271+CD106+CD146+ (NGFR+/VCAM1+/MCAM+/Lin-; NVML) cells display stem cell characteristics, are compatible with murine BM- derived Leptin receptor positive MSCs and provide superior support for normal HSPCs. MSC subsets from 17 patients with MDS demonstrated shared transcriptional changes in spite of mutational heterogeneity in the MDS clones, with loss of preferential support of normal HSPCs by MDS-derived NVML cells. Our data provide a new approach to dissect microenvironment-dependent mechanisms regulating clonal dynamics and progression to MDS.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.